3933 — United Laboratories International Holdings Share News
0.000.00%
Last trade - 00:00- HK$14.32bn
- HK$8.41bn
- CNY13.21bn
Novo Nordisk secures license to weight-loss drug candidate from China's United Labs
Brief: United Laboratories International Says Polyvinyl Alcohol Eye Drops Approved By NMPA
Brief: United Laboratories International Says US FDA Approved UBT251 Injection For Phase II Clinical Trial
Brief: United Laboratories International Announces Approval For Clinical Trial Of UBT251 Injection
Brief: United Laboratories International Says Mupirocin Ointment Submitted By Unit Approved By NMPA
Brief: United Laboratories International Says Ceftazidime For Injection Passed Consistency Evaluation By NMPA
Brief: United Laboratories International's Product Amoxicillin Granules Passed Consistency Evaluation
Brief: NMPA Accepts Application By United Laboratories International's Unit For Marketing A Drug
Brief: United Laboratories International Declares Interim Dividend Per Share RMB16.0 Cents
Brief: United Laboratories International Sees Net Profit Of RMB1.45 Bln For Six Months
Focus: Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Factbox: Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic
Focus: Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Brief: United Laboratories International Says Amoxicillin Clavulanate Potassium Tablets Passed Consistency Evaluation
Brief: United Laboratories International Participates In Bidding For National Centralised Procurement Of Pharmaceuticals
Brief: United Laboratories International Posts FY Profit Attributable RMB2.70 Bln Versus RMB1.58 Bln
United Laboratories hits 5-month peak on robust earnings estimates
Brief: United Laboratories International Sees Net Profit Of RMB2.60 Bln For Year
Brief: United Laboratories International Updates On Imipenem & Cilastatin Sodium For Injection